Recognized standard
F2312-11 (Reapproved 2020)
FDA recognition 15-31 · ASTM · Tissue Engineering
Key facts
| Recognition number | 15-31 |
|---|---|
| Designation | F2312-11 (Reapproved 2020) |
| Title | Standard Terminology Relating to Tissue Engineered Medical Products |
| Standards developer | ASTM International |
| Specialty area | Tissue Engineering |
| Date of entry | Mar 16, 2012 |
| Scope (excerpt) | 1.1 This terminology defines basic terms and presents the relationships of the scientific fields related to Tissue Engineered Medical Products (TEMPs). Committee F04 has defined these terms for the specific purpose of unifying the language used in standards for TEMPs. 1.2 The terms and relationships… |
At a glance
- None Product codes
- 1–9 FDA guidance documents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA-recognized consensus standards
The FDA recognizes voluntary consensus standards that manufacturers can cite in premarket submissions to show conformity with specific requirements.
Source: U.S. Food and Drug Administration (FDA), Recognized Consensus Standards database · Source date: